Maximum Recommended Dose of Paxil (Paroxetine)
The maximum recommended dose of Paxil (paroxetine) for adults is 50 mg per day for depression, 75 mg per day for panic disorder, and 60 mg per day for other indications, though most patients achieve optimal benefit at lower doses.
FDA-Approved Maximum Doses by Indication
The FDA drug label 11 specifies different maximum doses depending on the indication:
- Major Depressive Disorder: Maximum 62.5 mg/day (Paxil CR) or 50 mg/day (immediate-release)
- Panic Disorder: Maximum 75 mg/day (Paxil CR)
- Social Anxiety Disorder: Maximum 37.5 mg/day (Paxil CR)
- Premenstrual Dysphoric Disorder: Maximum 25 mg/day (Paxil CR)
Clinical Guidelines Support Lower Dosing
Multiple clinical guidelines consistently recommend 40 mg per day as the maximum effective dose for most adult patients 223. The 2015 American Family Physician guideline lists paroxetine's dosage range as 20-50 mg per day 33, with the starting dose at 10-20 mg daily.
For elderly patients (≥65 years), the maximum recommended dose is 40 mg per day 22, with a starting dose of 10 mg daily. This lower ceiling reflects increased risk of adverse effects in older adults, including anticholinergic effects and drug interactions 33.
Optimal Dosing Strategy
Most patients achieve therapeutic benefit at 20 mg daily 456. Research demonstrates that the dose-efficacy curve for SSRIs, including paroxetine, shows gradual improvement up to 20-40 mg fluoxetine equivalents (approximately 20-40 mg paroxetine), then flattens or decreases at higher doses 6. Meanwhile, adverse effects increase steeply throughout the dose range.
If initiating treatment:
- Start at 10-20 mg daily (10 mg in elderly or those prone to side effects)
- Increase by 10 mg increments no more frequently than weekly intervals 15
- Target dose: 20 mg daily for most patients 45
- Maximum: 40-50 mg daily for non-elderly adults who don't respond to lower doses 233
Critical Caveats
Paroxetine is NOT recommended as first-line in older adults due to higher anticholinergic effects compared to other SSRIs 33. Preferred alternatives include citalopram, escitalopram, or sertraline.
Discontinuation syndrome risk: Paroxetine has the highest risk among SSRIs for withdrawal symptoms 73. Always taper slowly over 10-14 days when discontinuing 22.
CYP2D6 considerations: For CYP2D6 poor metabolizers, paroxetine exposure increases 3.8-fold 89. These patients may require only 25% of standard dosing (maximum 10-15 mg daily). Intermediate metabolizers may need 50% dose reduction 8.
Suicidal behavior risk: Young adults (18-29 years) on paroxetine show increased risk of suicidal behavior, particularly in the first month of treatment 10. The number needed to harm is 370 for this age group 10.